Current status of endomyocardial biopsy

Mayo Clinic Proceedings

Volumn 86, Issue 11, 2011, Pages 1095-1102

  From, Aaron M ^a   Maleszewski, Joseph J ^a   Rihal, Charanjit S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC GRAFT REJECTION; CARDIOMYOPATHY; ECHOCARDIOGRAPHY; FEMORAL VEIN; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART SCINTISCANNING; HEART TUMOR; HEMATOMA; HUMAN; JUGULAR VEIN; LABORATORY TEST; MEDICAL RESEARCH; MYOCARDIAL DISEASE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; TECHNIQUE; TRICUSPID VALVE REGURGITATION; VASCULAR ACCESS;

EID: 80055098518     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2011.0296     Document Type: Review

References (71)

1. Caves PK, Stinson EB, Graham AF, Billingham ME, Grehl TM, Shumway NE. Percutaneous transvenous endomyocardial biopsy. JAMA. 1973;225:288-291.
2. Richardson PJ. King's endomyocardial bioptome. Lancet. 1974;1:660-661.
3. Anderson JL, Marshall HW. The femoral venous approach to endomyocardial biopsy: comparison with internal jugular and transarterial approaches. Am J Cardiol. 1984;53:833-837. (Pubitemid 14154701)
4. Ardehali H, Kasper EK, Baughman KL. Diagnostic approach to the patient with cardiomyopathy: whom to biopsy. Am Heart J. 2005;149:7-12. (Pubitemid 40126485)
5. Miller LW, Labovitz AJ, McBride LA, Pennington DG, Kanter K. Echocardiography-guided endomyocardial biopsy: a 5-year experience. Circulation. 1988;78(5 pt 2):III99-III102.
6. Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007;116:2216-2233. (Pubitemid 350060359)
7. Blomstrom-Lundqvist C, Noor AM, Eskilsson J, Persson S. Safety of transvenous right ventricular endomyocardial biopsy guided by two-dimensional echocardiography. Clin Cardiol. 1993;16:487-492. (Pubitemid 23164235)
8. Han J, Park Y, Lee H, et al. Complications of 2-D echocardiography guided transfemoral right ventricular endomyocardial biopsy. J Korean Med Sci. 2006;21:989-994.
9. Amitai ME, Schnittger I, Popp RL, Chow J, Brown P, Liang DH. Comparison of three-dimensional echocardiography to two-dimensional echocardiography and fluoroscopy for monitoring of endomyocardial biopsy. Am J Cardiol. 2007;99:864-866. (Pubitemid 46365610)
10. Platts D, Brown M, Javorsky G, West C, Kelly N, Burstow D. Comparison of fluoroscopic versus real-time three-dimensional transthoracic echocardiographic guidance of endomyocardial biopsies. Eur J Echocardiogr. 2010;11(7):637-643.
11. Fowles RE, Mason JW. Endomyocardial biopsy. Ann Intern Med. 1982;97:885-894. (Pubitemid 13240573)
12. Hiramitsu S, Hiroe M, Uemura A, Kimura K, Hishida H, Morimoto S. National survey of the use of endomyocardial biopsy in Japan. Jpn Circ J. 1998;62:909-912.
13. Nippoldt TB, Edwards WD, Holmes DR Jr, Reeder GS, Hartzler GO, Smith HC. Right ventricular endomyocardial biopsy: clinicopathologic correlates in 100 consecutive patients. Mayo Clin Proc. 1982;57:407-418. (Pubitemid 12013980)
14. Drury JH, Labovitz AJ, Miller LW. Echocardiographic guidance for endomyocardial biopsy. Echocardiography. 1997;14:469-474. (Pubitemid 27402760)
15. Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol. 1992;19:43-47.
16. Baraldi-Junkins C, Levin HR, Kasper EK, Rayburn BK, Herskowitz A, Baughman KL. Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant. 1993;12:63-67. (Pubitemid 23099861)
17. Ragni T, Martinelli L, Goggi C, et al. Echo-controlled endomyocardial biopsy. J Heart Transplant. 1990;9:538-542. (Pubitemid 20364447)
18. Wong RC, Abrahams Z, Hanna M, et al. Tricuspid regurgitation after cardiac transplantation: an old problem revisited. J Heart Lung Transplant. 2008;27:247-252. (Pubitemid 351375116)
19. Sloan KP, Bruce CJ, Oh JK, Rihal CS. Complications of echocardiography-guided endomyocardial biopsy. J Am Soc Echocardiogr. 2009;22(3):324. e1-324.e4.
20. Baim DS. Endomyocardial biopsy. In: Baim DS, Grossman W, eds. Grossman's Cardiac Catheterization, Angiography, and Intervention. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000:198-205.
21. Kreher SK, Ulstad VK, Dick CD, DeGroff R, Olivari MT, Homans DC. Frequent occurrence of occult pulmonary embolism from venous sheaths during endomyocardial biopsy. J Am Coll Cardiol. 1992;19:581-585.
22. Sekiguchi M, Take M. World survey of catheter biopsy of the heart. In: Sekiguchi M, Olsen EG, eds. Cardiomyopathy: Clinical, Logical and Theortical Aspects. Baltimore, MD: Univeristy Park Press; 1980:217-225.
23. Sandhu JS, Uretsky BF, Zerbe TR, et al. Coronary artery fistula in the heart transplant patient: a potential complication of endomyocardial biopsy. Circulation. 1989;79:350-356. (Pubitemid 19055506)
24. Chan MC, Giannetti N, Kato T, et al. Severe tricuspid regurgitation after heart transplantation. J Heart Lung Transplant. 2001;20:709-717. (Pubitemid 32633867)
25. Huddleston CB, Rosenbloom M, Goldstein JA, Pasque MK. Biopsyinduced tricuspid regurgitation after cardiac transplantation. Ann Thorac Surg. 1994;57:832-836.
26. Tucker PA II, Jin BS, Gaos CM, Radovancevic B, Frazier OH, Wilansky S. Flail tricuspid leaflet after multiple biopsies following orthotopic heart transplantation: echocardiographic and hemodynamic correlation. J Heart Lung Transplant. 1994;13:466-472. (Pubitemid 24168333)
27. Nguyen V, Cantarovich M, Cecere R, Giannetti N. Tricuspid regurgitation after cardiac transplantation: how many biopsies are too many? J Heart Lung Transplant. 2005;24:S227-S231. (Pubitemid 40922654)
28. Burgess MI, Aziz T, Yonan N. Clinical relevance of subclinical tricuspid regurgitation after orthotopic cardiac transplantation [letter]. J Am Soc Echocardiogr. 1999;12(2):164. (Pubitemid 29091783)
29. Jeevanandam V, Russell H, Mather P, Furukawa S, Anderson A, Raman J. Donor tricuspid annuloplasty during orthotopic heart transplantation: long-term results of a prospective controlled study. Ann Thorac Surg. 2006;82:2089-2095.
30. Cunningham KS, Veinot JP, Butany J. An approach to endomyocardial biopsy interpretation. J Clin Pathol. 2006;59:121-129. (Pubitemid 43235574)
31. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc. 1989;64:1235-1245. (Pubitemid 20005759)
32. Zerbe TR, Arena V. Diagnostic reliability of endomyocardial biopsy for assessment of cardiac allograft rejection. Hum Pathol. 1988;19:1307-1314. (Pubitemid 19005632)
33. Toor AA, Ramdane BA, Joseph J, et al. Cardiac nonamyloidotic immunoglobulin deposition disease. Mod Pathol. 2006;19:233-237. (Pubitemid 43117607)
34. Schultz JC, Hilliard AA, Cooper LT Jr, Rihal CS. Diagnosis and treatment of viral myocarditis. Mayo Clin Proc. 2009;84:1001-1009.
35. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation. 2003;107:857-863. (Pubitemid 36241044)
36. Ardehali H, Qasim A, Cappola T, et al. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am Heart J. 2004;147:919-923. (Pubitemid 38881009)
37. Mason JW, O'Connell JB. Clinical merit of endomyocardial biopsy. Circulation. 1989;79:971-979. (Pubitemid 19129177)
38. Bhat G, Burwig S, Walsh R. Morbidity of endomyocardial biopsy in cardiac transplant recipients. Am Heart J. 1993;125:1180-1181. (Pubitemid 23117362)
39. Pham MX, Teuteberg JJ, Kfoury AG, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med. 2010;362:1890-1900.
40. Horwitz PA, Tsai EJ, Putt ME, et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation. 2004;110:3815-3821. (Pubitemid 40028320)
41. Mehra MR, Parameshwar J. Gene expression profiling and cardiac allograft rejection monitoring: is IMAGE just a mirage? J Heart Lung Transplant. 2010;29:599-602.
42. White JA, Guiraudon C, Pflugfelder PW, Kostuk WJ. Routine surveillance myocardial biopsies are unnecessary beyond one year after heart transplantation. J Heart Lung Transplant. 1995;14:1052-1056. (Pubitemid 26008636)
43. Stehlik J, Starling RC, Movsesian MA, et al. Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis. J Heart Lung Transplant. 2006;25:1402-1409. (Pubitemid 44909475)
44. Kucirka LM, Maleszewski JJ, Segev DL, Halushka MK. Survey of North American pathologist practices regarding antibody-mediated rejec- tion in cardiac transplant biopsies. Cardiovasc Pathol. 2011;20(3):132-138.
45. Cooper LT Jr, Berry GJ, Shabetai R; Multicenter Giant Cell Myocarditis Study Group Investigators. Idiopathic giant-cell myocarditis: natural history and treatment. N Engl J Med. 1997;336:1860-1866. (Pubitemid 27263973)
46. deMello DE, Liapis H, Jureidini S, Nouri S, Kephart GM, Gleich GJ. Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med. 1990;323:1542-1545.
47. Taliercio CP, Olney BA, Lie JT. Myocarditis related to drug hypersensitivity. Mayo Clin Proc. 1985;60:463-468. (Pubitemid 15249995)
48. Mills RM, Lauer MS. Endomyocardial biopsy: a procedure in search of an indication. Am Heart J. 2004;147:759-760. (Pubitemid 38880978)
49. Chow LH, Radio SJ, Sears TD, McManus BM. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol. 1989;14:915-920. (Pubitemid 19250576)
50. Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;82:537-540. (Pubitemid 28389961)
51. Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest. 2008;133:1426-1435. (Pubitemid 351893001)
52. Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009;157:9-21.
53. Okura Y, Dec GW, Hare JM, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003;41:322-329.
54. Ardehali H, Howard DL, Hariri A, et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J. 2005;150:459-463. (Pubitemid 41317613)
55. Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med. 2000;45:107-137.
56. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337:898-909. (Pubitemid 27408573)
57. Dubrey SW, Cha K, Skinner M, LaValley M, Falk RH. Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes. Heart. 1997;78:74-82. (Pubitemid 27346885)
58. Skinner M, Sanchorawala V, Seldin DC, et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004;140:85-93.
59. Frustaci A, Chimenti C, Ricci R, et al. Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. N Engl J Med. 2001;345:25-32. (Pubitemid 32634268)
60. Eng CM, Guffon N, Wilcox WR, et al. Safety and efficacy of recombinant human alpha-galactosidase A: replacement therapy in Fabry's disease. N Engl J Med. 2001;345:9-16. (Pubitemid 32634266)
61. Fawzy ME, Ziady G, Halim M, Guindy R, Mercer EN, Feteih N. Endomyocardial fibrosis: report of eight cases. J Am Coll Cardiol. 1985;5:983-988. (Pubitemid 15110153)
62. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. 1997;336:267-276. (Pubitemid 27044630)
63. Tadamura E, Yamamuro M, Kubo S, et al. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation. 2006;113:e771-e773. (Pubitemid 43948038)
64. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J. 1999;138:299-302. (Pubitemid 29379681)
65. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186-193. (Pubitemid 40139730)
66. Auriti A, Pandozi C, Altamura V, Cianfrocca C, Manente L, Santini M. Transthoracic echocardiography-guided biopsy of a right ventricular mass. J Cardiovasc Med (Hagerstown). 2007;8:274-276. (Pubitemid 46586664)
67. Unger P, Kentos A, Cogan E, Renard M, Crasset V, Stoupel E. Primary cardiac lymphoma: diagnosis by transvenous biopsy under transesophageal echocardiographic guidance. J Am Soc Echocardiogr. 1998;11:89-91. (Pubitemid 28158538)
68. Meinardi MT, van der Graaf WT, van Veldhuisen DJ, Gietema JA, de Vries EG, Sleijfer DT. Detection of anthracycline-induced cardiotoxicity. Cancer Treat Rev. 1999;25:237-247. (Pubitemid 29417681)
69. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med. 1996;125:47-58.
70. Vignola PA, Aonuma K, Swaye PS, et al. Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression. J Am Coll Cardiol. 1984;4:812-819. (Pubitemid 14012472)
71. Kobayashi Y, Yazawa T, Baba T, et al. Clinical, electrophysiological, and histopathological observations in supraventricular tachycardia. Pacing Clin Electrophysiol. 1988;11:1154-1167. (Pubitemid 19004598)